GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Clover Health Investments Corp (NAS:CLOV) » Definitions » Piotroski F-Score

Clover Health Investments (Clover Health Investments) Piotroski F-Score : 4 (As of Apr. 29, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clover Health Investments Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Clover Health Investments has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Clover Health Investments's Piotroski F-Score or its related term are showing as below:

CLOV' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 4   Max: 4
Current: 4

During the past 5 years, the highest Piotroski F-Score of Clover Health Investments was 4. The lowest was 4. And the median was 4.


Clover Health Investments Piotroski F-Score Historical Data

The historical data trend for Clover Health Investments's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Health Investments Piotroski F-Score Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
N/A N/A 4.00 4.00 4.00

Clover Health Investments Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.00 5.00 4.00 4.00

Competitive Comparison of Clover Health Investments's Piotroski F-Score

For the Healthcare Plans subindustry, Clover Health Investments's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clover Health Investments's Piotroski F-Score Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Clover Health Investments's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -72.606 + -28.814 + -41.469 + -70.472 = $-213 Mil.
Cash Flow from Operations was 79.032 + 53.173 + -18.781 + -229.295 = $-116 Mil.
Revenue was 527.775 + 513.628 + 482.066 + 510.251 = $2,034 Mil.
Gross Profit was 55.285 + 76.674 + 63.107 + 62.266 = $257 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(808.62 + 1453.589 + 1257.997 + 1059.797 + 570.671) / 5 = $1030.1348 Mil.
Total Assets at the begining of this year (Dec22) was $809 Mil.
Long-Term Debt & Capital Lease Obligation was $3 Mil.
Total Current Assets was $428 Mil.
Total Current Liabilities was $261 Mil.
Net Income was -75.49 + -104.362 + -75.489 + -84.226 = $-340 Mil.

Revenue was 874.379 + 846.7 + 856.817 + 898.791 = $3,477 Mil.
Gross Profit was 12.657 + -12.086 + 17.018 + 5.146 = $23 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(950.804 + 2679.894 + 2063.206 + 1557.679 + 808.62) / 5 = $1612.0406 Mil.
Total Assets at the begining of last year (Dec21) was $951 Mil.
Long-Term Debt & Capital Lease Obligation was $4 Mil.
Total Current Assets was $625 Mil.
Total Current Liabilities was $432 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Clover Health Investments's current Net Income (TTM) was -213. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Clover Health Investments's current Cash Flow from Operations (TTM) was -116. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-213.361/808.62
=-0.26385818

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-339.567/950.804
=-0.3571367

Clover Health Investments's return on assets of this year was -0.26385818. Clover Health Investments's return on assets of last year was -0.3571367. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Clover Health Investments's current Net Income (TTM) was -213. Clover Health Investments's current Cash Flow from Operations (TTM) was -116. ==> -116 > -213 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=2.998/1030.1348
=0.0029103

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=4.033/1612.0406
=0.0025018

Clover Health Investments's gearing of this year was 0.0029103. Clover Health Investments's gearing of last year was 0.0025018. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=427.97/261.115
=1.63900963

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=624.997/431.507
=1.44840524

Clover Health Investments's current ratio of this year was 1.63900963. Clover Health Investments's current ratio of last year was 1.44840524. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Clover Health Investments's number of shares in issue this year was 485.94. Clover Health Investments's number of shares in issue last year was 478.148. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=257.332/2033.72
=0.12653266

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=22.735/3476.687
=0.00653927

Clover Health Investments's gross margin of this year was 0.12653266. Clover Health Investments's gross margin of last year was 0.00653927. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=2033.72/808.62
=2.51505033

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=3476.687/950.804
=3.65657591

Clover Health Investments's asset turnover of this year was 2.51505033. Clover Health Investments's asset turnover of last year was 3.65657591. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+1+0+1+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Clover Health Investments has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Clover Health Investments  (NAS:CLOV) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Clover Health Investments Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Clover Health Investments's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Clover Health Investments (Clover Health Investments) Business Description

Traded in Other Exchanges
Address
3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, & analyze health & behavioral data to improve medical outcomes & lower costs for patients. The Group has two operating segments. The insurance segment provides PPO(Preferred provider Organization) & HMO(Health Maintenance Organization) plans to Medicare Advantage members in several states & seeks to improve care & lower costs which generally provide access to a wide network of primary care providers, specialists, & hospitals. Non-insurance segment includes the Company's operations relating to CMS' DC (Direct Contracting) Model, which provides options aimed at reducing expenditures & preserving or enhancing the quality of care for beneficiaries.
Executives
Karen Soares officer: General Counsel & Secretary 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Clover Health Investments, Corp. /de officer: Chief Technology Officer 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Anna U Loengard director C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Andrew Toy director, officer: Chief Executive Officer C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Scott J. Leffler officer: Chief Financial Officer C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Brady Patrick Priest officer: CEO of Home Care C/O CLOVER HEALTH INVESTMENTS, CORP., FRANKLIN TN 37067
Demetrios L. Kouzoukas director C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN FL 37067
Aric R Sharp officer: CEO of Value-Based Care C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Wai Conrad officer: Chief Technology Officer 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Joseph Richards Martin officer: General Counsel C/O LOUISIANA-PACIFIC CORPORATION, 414 UNION STREET, SUITE 2000, NASHVILLE TN 37219
Vivek Garipalli director, 10 percent owner, officer: Executive Chairperson C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Carladenise Armbrister Edwards director C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Chelsea Clinton director C/O IAC 555 W 18TH STREET, NEW YORK NY 10011
Jamie L. Reynoso officer: CEO of Medicare Advantage C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Chamath Palihapitiya 10 percent owner, other: See Remarks THE SOCIAL-CAPITAL PARTNERSHIP, L.L.C., 506 SANTA CRUZ AVENUE, SUITE 300, MENLO PARK CA 94025

Clover Health Investments (Clover Health Investments) Headlines

From GuruFocus

Clover Health Issues December 2022 Investor Frequently Asked Questions

By Value_Insider Value_Insider 12-13-2022

Clover Health Provides Business Update and Issues Partial Guidance for Full-Year 2023

By Stock market mentor Stock market mentor 01-10-2023

Dr. Anna Loengard Joins Clover Health Board of Directors

By Value_Insider Value_Insider 11-30-2022